Participated · Series A · Aug 2026

Founded in 2021 by Neeraj Biyani, Eeti Sharma and Mandeep Singh Bhatia, Asaya develops a full hyperpigmentation regimen spanning cleansers, serums, spot treatments, moisturizers and sunscreens. The company is developing MelaMe, a proprietary, patent-pending complex it says is clinically proven to reduce hyperpigmentation faster, and it reinvests up to 18% of revenue into R&D. Asaya reports an annual revenue run rate of Rs 100 crore and is targeting Rs 200 crore ARR within 18 months. Its products are available across over 18,000 pin codes, with more than 2,000 pin codes receiving deliveries within 24 hours. The company plans to expand distribution via quick-commerce platforms and offline retail partnerships as part of its growth strategy. Executives said five of Asaya’s top eight products now outperform repeat-purchase rates of leading brands in their categories.

Led · Seed · Jul 2026

CUNIN operates in the fragrance segment and offers carryable perfume accessories designed to be worn, clipped, and carried. Its debut collection, The World of Antonyms, applies a creative theme across products, packaging, and branding and features personalities such as IM-Perfect, DIS-Loyal, MIS-Placed, and MIS-Aligned. The company sells its products via its website and plans to expand its fragrance portfolio, invest in content, brand experiences, and community initiatives, and enter adjacent lifestyle categories. Founders are Kunal Shukla, Amish Bibhu, and Afsal. Following the $450K pre-seed raise, CUNIN intends to use the funds to accelerate product development, grow the team, build the brand, and expand offline presence.

Participated · Series A · Mar 2026

Launched in 2025 and based in Gurugram, OZi is a quick commerce platform offering curated baby and kids’ products across categories such as apparel, toys, baby gear, nursing and feeding essentials, baby care, school essentials, pharmacy items, everyday consumables, gifting, and larger gear. The platform offers over 15,000 products for children aged 0–12 and operates 24x7 with delivery within 60 minutes plus scheduled delivery options. Since launching in Gurugram, OZi reported 12x growth within five months and has expanded service to Noida. The company positions itself for rapid geographic expansion across the NCR as part of its growth strategy. OZi plans to use its Series A proceeds to strengthen brand and trust, invest in technology and operational capabilities, and expand its curated assortment. These initiatives are intended to deepen its presence in Gurugram and the broader NCR market.

Participated · Series A · Feb 2026

Founded in 2023 by Amar Sneh and Deepak Kumar, Oncare operates a multi-centre oncology platform that integrates medical, surgical and radiation oncology services within accredited hospitals. Its capital-efficient model allows the company to open centres inside existing hospital infrastructure, giving patients a one-stop destination for comprehensive cancer care. The startup currently runs four centres across Delhi NCR and has built this footprint within three years of launch. Oncare’s platform emphasises care coordination and patient experience, supported by proprietary technology that streamlines clinical operations. With fresh capital, the company plans to enter additional metro markets as well as tier-II and tier-III cities, accelerating its path to nationwide coverage. The focus areas for investment include expanding centre count, strengthening technology infrastructure and enhancing patient-facing services. While no revenue figures were disclosed, the company has raised $5 million to date to fund its rapid expansion.

Led · Seed · Jan 2026

Founded in 2024 by Shreya Jain and Kshitij Rihal, The Stack is a consumer health startup that formulates supplements using clinically studied ingredients sourced from global suppliers. The company follows a limited, quality-first product strategy, concentrating on clearly defined use cases like sleep support and gut health while maintaining end-to-end supply-chain transparency. Over the past year, The Stack says it has built a multi-category consumer health business with improving unit economics, and certain products have grown more than 40× in 12 months. Repeat purchase rates range from 35 % to 50 % at the SKU level within mature customer cohorts, indicating strong retention. The newly raised capital will be deployed toward R&D, expanding the product pipeline, hiring its early team, and enhancing branding and packaging. Looking ahead, the founders plan to keep the portfolio intentionally small, focusing on highly differentiated, science-backed formulations that address lifestyle-linked health concerns. Their emphasis on transparency and evidence-based ingredients positions them to capture health-conscious consumers seeking credible supplement options.